Document is current

Article History

Received: 11 May 2020

Accepted: 7 July 2020

First Online: 16 July 2020

Compliance with ethical standards

:

: EML has received no direct income from potentially conflicting entities. His employer, New Mexico Clinical Research & Osteoporosis Center, has received research grants from Radius, Amgen, Mereo, Bindex; income for service on scientific advisory boards or consulting for Amgen, Radius, Alexion, Sandoz, Samsung Bioepis, Sanifit; service on speakers’ bureaus for Radius, Alexion; project development for University of New Mexico; and royalties from UpToDate for sections on DXA, fracture risk assessment, and prevention of osteoporosis. He is a board member of the National Osteoporosis Foundation, International Society for Clinical Densitometry, and Osteoporosis Foundation of New Mexico.NB has nothing to declare for the content of this manuscript, but has received research support (paid to institution) from Radius; consultant/advisory board fees from Amgen.PC has received grant/research support from CONACYT (Mexico) Fondos Federales (Mexico);consultant/speakers’ bureau/advisory activities with Amgen, Eli Lilly, and Pfizer; board.membership with IOF and National University of Mexico UNAM.SK has no financial or industry related conflicts of interest; she is chair of the Scientific Advisory Council for Osteoporosis Canada, co-chair of the pharmacotherapy working group for the Osteoporosis Canada Clinical Practice Guidelines Update, and serves on the Osteoporosis Canada Board of Directors.WDL has no financial or industry-related conflicts of interest; he is chair of the steering committee for the Osteoporosis Canada Clinical Practice Guidelines Update.SNM is a member of the steering committee for the Osteoporosis Canada Clinical Practice Guidelines Update; she has received a research grant from Amgen (paid to research institution).